Supreme Court Upholds Broad Access to Abortion Pill

“The Supreme Court on Thursday upheld access to a widely available abortion pill, rejecting a bid from a group of anti-abortion organizations and doctors to unravel the Food and Drug Administration’s approval of the pill,” the New York Times reports.

“In a unanimous decision, written by Justice Brett Kavanaugh, the court held that the plaintiffs lacked standing to challenge the FDA’s actions.”

“The challenge to the availability of mifepristone, a medication used in a majority of abortions in the country, reflected one of the latest fronts over abortion access. The case had returned the abortion issue back to the Supreme Court, even as the conservative majority, in overturning Roe v. Wade, declared that it would cede the question ‘to the people and their elected representatives.'”

Wall Street Journal: “The ruling ensures the pills, which are the most common method for ending a pregnancy in the U.S., will for now remain widely available.”

Washington Post: “Ever since the high court eliminated the nationwide right to abortion in 2022, medications to terminate pregnancy have increased in importance and become a major target of litigation, in part because the pills can be sent by mail, including to states that have severely limited or banned abortions.”